Top 20 Most Heavily Promoted Penny Stocks For May 2013

Pink Sheets
MULI	Multi-Corp Internation...
ITNS	ITonis, Inc.
FITX	Creative Edge Nutritio...
SMAA	SMA Alliance, Inc.
EVSV	Enviro-Serv. Inc.
WTII	Water Technologies Int...
GDTK	GDT Tek Inc.
DNAD	Dna Dynamics, Inc.
MXAM	Maxam Gold Corp.
MELY	Microelectronics Techn...

OTC BB
POLR	Polar Petroleum Corp.
XUII	Xumanii, Inc.
TRTC	Terra Tech Corp.
SRBL	Great American Energy,...
LRDR	Laredo Resources Corp.
GOFF	Goff Corp.
GNIN	Green Innovations Ltd.
TALK	iTalk, Inc.
GLDN	Gold Dynamics Corp.
OLIE	Olie Inc.

BROWSE COMPANIES

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9

Analyst Recommendation for Pain Therapeutics, Inc (PTIE)

Watch the video to learn about the probability of Pain Therapeutics, Inc (PTIE) Chart Signal as of May 18 2013

Hotstocked Precision will calculate the probabilities of Pain Therapeutics, Inc (PTIE)

Rating:
Size:	656KB
Version:	1.1
Platform:	Win/Mac
Downloads:

FREE DOWNLOAD

Company

Analyst Information for Pain Therapeutics

After Hours: $ 2.85

-0.04 (-1.38%)

Volume: 5.22 k

6:05 PM EDT May 17, 2013

Consensus Rating Average

Consensus Rating for PTIE is MODERATE BUY

Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).

Rating Scale

	Strong Buy	1.0 - 1.5
	Moderate Buy	1.6 - 2.5
	Hold	2.6 - 3.5
	Moderate Sell	3.6 - 4.5
	Strong Sell	4.6 - 5.0

Consensus Rating Details

Current Average Recommendation	2.33
Previous Average Recommendation	1.67
Change in Average Recommendation	0.66
Number of Analysts Reporting	3

Strong Buy
1.0

Current: 2.33

Previous: 1.67

Change: 0.66

Strong Sell
5.0

Consensus Rating Industry Comparison

Industry: MED-DRUGS
Number of companies in industry with recommendations	97
Rank Recommendation relative to companies in its industry	83

Ranked 83 in Industry

197 MED-DRUGS

Analyst Recommendations

Analysts recommending Strong Buy	1
Analysts recommending Moderate Buy	0
Analysts recommending Hold	2
Analysts recommending Moderate Sell	0
Analysts recommending Strong Sell	0

Recommendations History

	Current	1 Month Ago	2 Months Ago	3 Months Ago
Strong Buy	1	2	2	2
Moderate Buy	0	0	0	0
Hold	2	1	1	1
Moderate Sell	0	0	0	0
Strong Sell	0	0	0	0
Mean Rec.	2.33	1.67	1.67	1.67

Copyright © QuoteMedia. Data delayed at least 15 min. unless otherwise indicated. RT = Realtime, EOD = End Of Day, PD = Previous Day. Market Data powered by QuoteMedia, analyst ratings by Zacks. Terms of Use.